Evidence for infectious agents in cardiovascular disease and atherosclerosis

被引:187
作者
Leinonen, M
Saikku, P
机构
[1] Natl Publ Hlth Inst, FIN-90101 Oulu, Finland
[2] Univ Oulu, Dept Med Microbiol, Oulu, Finland
关键词
D O I
10.1016/S1473-3099(01)00168-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
During the past decade, several novel risk factors for atherosclerosis, including inflammation and infections, have been reported. Seroepidemiological studies suggest an association between several microbes and coronary heart disease. Microbes or their structural components are found in atherosclerotic plaques, but the only intact microbes commonly present are herpes viruses and Chlamydia pneumoniae. These agents are able to initiate and accelerate atherosclerosis in animal models. If they cause persistent infection in the vessel wall, they can directly promote a proinflammatory, procoagulant, and proatherogenic environment. Microbes could also have a remote effect-eg, bacterial heat shock proteins with high sequence homology with human counterpart could, in the presence of a chronic infection, induce autoimmunity against vascular cells, and lead to an atherosclerotic process. Several intervention trials with antibiotics are underway, and will hopefully shed new light on the role of bacteria in atherosclerosis. The causal relationship can be proved by use of vaccination to prevent infections.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 79 条
[1]   Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice [J].
Aalto-Setälä, K ;
Laitinen, K ;
Erkkilä, L ;
Leinonen, M ;
Jauhiainen, M ;
Ehnholm, C ;
Tamminen, M ;
Puolakkainen, M ;
Penttilä, I ;
Saikku, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :578-584
[2]   Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse [J].
Alber, DG ;
Powell, KL ;
Vallance, P ;
Goodwin, DA ;
Grahame-Clarke, C .
CIRCULATION, 2000, 102 (07) :779-785
[3]   Detection of Helicobacter pylori in human carotid atherosclerotic plaques [J].
Ameriso, SF ;
Fridman, EA ;
Leiguarda, RC ;
Sevlever, GE .
STROKE, 2001, 32 (02) :385-390
[4]   Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens [J].
Apfalter, P ;
Blasi, F ;
Boman, J ;
Gaydos, CA ;
Kundi, M ;
Maass, M ;
Makristathis, A ;
Meijer, A ;
Nadrchal, R ;
Persson, K ;
Rotter, ML ;
Tong, CYW ;
Stanek, G ;
Hirschl, AM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (02) :519-524
[5]   Chlamydia infections and heart disease linked through antigenic mimicry [J].
Bachmaier, K ;
Neu, N ;
de la Maza, LM ;
Pal, S ;
Hessel, A ;
Penninger, JM .
SCIENCE, 1999, 283 (5406) :1335-1339
[6]   VIRUSES IN THE ETIOLOGY OF ATHEROSCLEROSIS [J].
BENDITT, EP ;
BARRETT, T ;
MCDOUGALL, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (20) :6386-6389
[7]   High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors [J].
Boman, J ;
Söderberg, S ;
Forsberg, J ;
Birgander, LS ;
Allard, A ;
Persson, K ;
Jidell, E ;
Kumlin, U ;
Juto, P ;
Waldenström, A ;
Wadell, G .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :274-277
[8]   Cytomegalovirus and atherogenesis [J].
Bruggeman, CA ;
Marjorie, HJ ;
Nelissen-Vrancken, G .
ANTIVIRAL RESEARCH, 1999, 43 (03) :135-144
[9]  
Caligiuri G, 2001, CIRCULATION, V103, P2834
[10]   LP(A) LIPOPROTEIN, IGG, IGA AND IGM ANTIBODIES TO CHLAMYDIA-PNEUMONIAE AND HLA CLASS-II GENOTYPE IN EARLY CORONARY-ARTERY DISEASE [J].
DAHLEN, GH ;
BOMAN, J ;
BIRGANDER, LS ;
LINDBLOM, B .
ATHEROSCLEROSIS, 1995, 114 (02) :165-174